194 studies found for:    heart disease AND women OR coronary microvascular disease OR cardiac syndrome X | Open Studies | NIH, U.S. Fed
Show Display Options
Rank Status Study
21 Not yet recruiting Blood Lipopolysaccharide (LPS) Rifaximin Study
Conditions: Obese;   Insulin Resistance;   Metabolic Syndrome
Interventions: Drug: Rifaximin SSD;   Other: Placebo
22 Recruiting Endogenous Opioid Activity and Affective State in Insulin Resistant Women
Conditions: Depression;   Insulin Resistance;   Metabolic Syndrome
Intervention: Drug: Metformin
23 Unknown  Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic Syndrome
Condition: Metabolic Syndrome
Interventions: Drug: Zoladex;   Drug: AndroGel;   Drug: Arimidex
24 Recruiting The Health-Promoting Role of Pears in Men and Women With Metabolic Syndrome
Condition: Metabolic Syndrome
Interventions: Dietary Supplement: Pear;   Dietary Supplement: Placebo
25 Not yet recruiting Effects of Tart Cherry and Aroniaberry Supplementation on Endothelial Function and Cardiovascular Measures in Healthy Older Adults: Interactions With Genotype and Proteome
Conditions: Cardiovascular Disease;   Coronary Heart Disease;   Aging
Intervention:
26 Unknown  Environmental and Genetic Factors That Influence Cardiovascular Disease in African Americans
Conditions: Cardiovascular Diseases;   Heart Diseases;   Atherosclerosis;   Coronary Disease;   Hypertension;   Cerebrovascular Disorders
Intervention:
27 Recruiting Deep Reading as a Contemplative Practice for Women With Primary Ovarian Insufficiency
Condition: Ovarian Insufficiency
Intervention: Other: Group reading and discussion
28 Recruiting Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
Condition: Heart Failure
Interventions: Drug: Spironolactone;   Drug: Placebo
29 Recruiting Weight Loss Referral for Healthier Survivorship in Obese Stage I-II Endometrial Cancer Survivors or Atypical Hyperplasia
Conditions: Complex Endometrial Hyperplasia With Atypia;   Stage IA Uterine Corpus Cancer;   Stage IB Uterine Corpus Cancer;   Stage II Uterine Corpus Cancer
Interventions: Behavioral: Weight Loss Specialist;   Other: Quality-of-Life Assessment;   Other: Medical Chart Review
30 Recruiting Mifepristone for Metabolic Syndrome
Conditions: Endocrine Disease;   Diabetes
Intervention: Drug: Mifepristone
31 Recruiting HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy
Condition: Hypertrophic Cardiomyopathy
Intervention: Other: None - this is an observational study
32 Recruiting Impact of Graphic Cigarette Warnings
Condition: Smoking
Interventions: Other: Surgeon General's Warning;   Other: Graphic Warning
33 Recruiting Eastern Caribbean Health Outcomes Research Network (ECHORN)
Conditions: Cancer;   Cardiovascular Disease;   Diabetes
Intervention:
34 Recruiting Effects of Amino Acids on Regional Lipid Metabolism
Condition: Hypertriglyceridemia
Interventions: Dietary Supplement: Amino acids;   Dietary Supplement: Placebo
35 Recruiting Mediators of Atherosclerosis in South Asians Living in America (MASALA) Social Network Study
Condition: Atherosclerosis
Intervention:
36 Recruiting Effect of Isotretinoin on Immune Activation Among HIV-1 Infected Subjects With Incomplete CD4+ T Cell Recovery
Condition: HIV-1 Infection
Intervention: Drug: Isotretinoin
37 Recruiting The Effects of Exenatide (Byetta ) on Energy Expenditure and Weight Loss in Nondiabetic Obese Subjects
Conditions: Weight Loss;   Obesity
Interventions: Drug: Byetta (exenatide);   Behavioral: Weight loss;   Other: Metabolic Chamber;   Drug: Placebo
38 Recruiting Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s Sarcoma
Condition: Sarcoma, Kaposi
Interventions: Drug: Liposomal Doxorubicin;   Drug: Bevacizumab
39 Recruiting Predicting Successful Sleep Apnea Treatment With Acetazolamide in Heart Failure Patients
Conditions: Heart Failure;;   Controls Without Heart Failure
Interventions: Drug: Acetazolamide;   Drug: Placebo
40 Recruiting Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM
Condition: Hypertrophic Cardiomyopathy
Interventions: Drug: Valsartan;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years